Vanda Pharmaceuticals
VNDA
NASDAQ
IPO2006
about VNDA
Vanda Pharmaceuticals specializes in developing treatments for rare diseases, particularly in neuroscience, with its lead product Hetlioz addressing sleep-wake disorders in individuals with vision loss.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.02 | $6.06 | $5.73 | $360.56M | 6.21M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.38 | n/a | 8.72 | -55.61% | -40.15% | 0% |